A single dose of an experimental influenza drug saves more mice from H5N1 avian influenza than the preferred drug Tamiflu, researchers reported on Thursday, and can also protect against infection. The tests of Daiichi Sankyo Co Ltd's CS 8958 or laninamivir show one inhaled dose worked better than Tamiflu to keep mice alive when infected with a normally deadly dose. The report in the Public Library of Science Journal PLoS Pathogens covers one of the dozens of ongoing studies of a new batch of influenza drugs being developed by a variety of companies.
via Pandemic Information News: New Inhaled Drug Protects from Flu in Single Dose.